NEW DELHI: Shares of . traded 1.01 per cent up in Monday’s trade at 11:01AM (IST). Around 12,736 shares changed hands on the counter.

The counter opened at Rs 536.5 and touched an intraday high and low of Rs 542.9 and Rs 536.1, respectively, in the session so far. The stock of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 767.45 and a 52-week low of Rs 503.4.

As per BSE, the total market cap of the Aurobindo Pharma Ltd. stood at Rs 31640.68 crore at the time of writing this report.

Key Financials

The company reported consolidated net sales of Rs 6276.54 crore for the quarter ended 30-Jun-2022, up 7.14 per cent from previous quarter’s Rs 5858.25 crore and up 8.53 per cent from the year-ago quarter’s Rs 5783.29 crore.

The net profit for latest quarter stood at Rs 520.54 crore, down 32.39 per cent from the same quarter a year ago.

Shareholding pattern

As of 30-Jun-2022, domestic institutional investors held 9.82 per cent stake in the firm, while foreign institutional investors held 20.71 per cent and the promoters 48.76 per cent.

Valuation ratio

According to BSE data, the stock traded at a price-to-earnings multiple of 13.19 and a price-to-book ratio of 1.59. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.

Aurobindo Pharma Ltd. belongs to the Pharma – Indian industry.


Source link

By Dipak

Leave a Reply

Your email address will not be published.